1James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults re- port from the panel members appointed to the eighth joint nation- al committee (JNCS)[J]. JAMA,2014,3"11(5) :507-520.
2Gifford RW Jr. The 1984 JNC report on hypertension (joint na- tional committee on detection, evaluation, and treatment of high blood pressure)[J]. Cleve Clin Q,1984,51(3):515-516.
3The }i{th report of the ioint national committee on detection, eval- uation, and treatment of high blood pressure(JNCV )[J]. Arch Intern Med,1993,153(2) : 154-183.
4Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure[J]. Hypertension, 2003,42 (6) 1206-1252.
5Dahl6 f B, Devereux RB, Kjeldsen SE, et al. Cardiovascular mor- bidity and mortality in the losartan intervention for endpoint re- duction in hypertension study (LIFE) : a randomised trial against atenolol[J]. Lancet,2002,359(9311) ..995-1003.
6Wikstrand J. Primary prevention in patients with hypertension, comments on the clinical implications of the MAPHY study. Metoprolol atherosclerosis prevention in hypertensives study[J]. Am Heart J,1988,116(1 Pt 2):338-347.
7Dahl6f B, Sever PS, Poulter NR, et al. Prevention of cardiovas- cular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflu- methiazide as required, in the Anglo-Scandinavian cardiac out- comes trial-blood pressure lowering arm (ASCOT-BPLA): a multicentre randomised controlled trial [ J ]. Lancet, 2005, 366 (9489) :895-906.
8Wilhelmsen L, Berglund G, Elmfeldt D, et al. Beta-blockers ver-sus diuretics in hypertensive men: main results from the HAPPHY trial[J]. J Hypertens, 1987,5(5) 561-572.
9The IPPPSH collaborative group. Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta-bloc- ker oxprenolol: the international prospective primary prevention study in hypertension (IPPPSH) [J]. J Hypertens, 1985,3 (4) 379-392.
10UK prospective diabetes study (UKPDS) group. Intensive blood- glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)[J]. Lancet,1998,352(9131) :837-853.
